John S. Montalbano - 04 Mar 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney in fact
Issuer symbol
ABCL
Transactions as of
04 Mar 2022
Net transactions value
+$85,400
Form type
4
Filing time
04 Mar 2022, 15:51:53 UTC
Previous filing
03 Mar 2022
Next filing
05 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $85,400 +10,000 +22% $8.54 56,000 04 Mar 2022 Direct
holding ABCL Common Shares 5,000 04 Mar 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.